<DOC>
	<DOCNO>NCT02153593</DOCNO>
	<brief_summary>Massive bone tumour resection often associate important postoperative bleeding . This may determine systemic ( anaemia ) , well local complication ( wound healing , seroma , haematoma ) . The objective study determine whether use topical tranexamic acid topical EvicelÂ® reduce perioperative bleeding compare usual haemostasis .</brief_summary>
	<brief_title>Postoperative Bleeding Prevention Massive Bone Tumour Resection</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Bone Neoplasms</mesh_term>
	<mesh_term>Postoperative Hemorrhage</mesh_term>
	<mesh_term>Fibrin Tissue Adhesive</mesh_term>
	<mesh_term>Tranexamic Acid</mesh_term>
	<criteria>18 year old Musculoskeletal tumor ( primary metastatic , benign malignant ) locate extremity , shoulder girdle pelvis . Massive bloc tumour resection . Patient 's consent participate Known allergy ATX Allergy know hypersensitivity bovine protein ( aprotinin ) Liposarcomas low grade History thromboembolic disease prothrombotic condition : cerebral vascular accident ischemic heart disease deep / superficial vein thrombosis pulmonary embolism peripheral arterial vasculopathy thrombogenic arrhythmia ( eg : ACxFA ) patient cardiovascular stent prothrombotic alteration coagulation Treatment contraceptive drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Clinical trial</keyword>
	<keyword>Randomized</keyword>
	<keyword>Fibrin glue</keyword>
	<keyword>Tranexamic acid</keyword>
	<keyword>Blood loss</keyword>
</DOC>